Saturday, September 25, 2021
News

DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine trials

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | August 3, 2020 7:11:57 PM IST
The The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on Monday.

"The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine," the Health Ministry said in a statement.

The ministry said India's Case Fatality Rate (CFR) now stands at 2.11 per cent.

"India continues to improve the Case Fatality Rate (CFR), and maintain its global position of having one of the lowest COVID fatality rates. With a further fall, the current CFR touched 2.11% today. This is the outcome of the well-conceived and effectively implemented strategy of "Test, Track and Treat" which has guided COVID management in the country," the ministry said.

India has seen more than 40,574 patients recovered in the last 24 hours. This takes the total recoveries to 11,86,203 and recovery rate to 65.77% amongst COVID-19 patients, the ministry said, adding that the gap between the recovered cases and the active cases has increased to more than 6 lakh.

"Presently, it is 6,06,846. This means the actual active caseload is 5,79,357 and all are under medical supervision," the ministry said. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Andhra CM gives nod for recruitment to 1...
Government to announce new Cooperative p...
Plea in HC seeks modification of Delhi g...
Kerala family stage protest after no act...
Property worth Rs 10 crore of Mukhtar An...
Objections to NEP natural, says LS Speak...
More...    
 
 Top Stories
Kamakshi Rai on her debut indie mus... 
Rohini shootout: plea moved in SC s... 
Latest excavations unearth glimpses... 
New Punjab Cabinet to take oath on ... 
Russian Investigative Committee say... 
Whatever happened between complaina... 
SC ends extension of limitation per... 
IMD issues Cyclone alert for Odisha...